Pfizer warns US about a shortage of coronavirus vaccine
Health
- 08 December, 2020
- 08:08
The US company Pfizer informed the Administration of President Donald Trump that it could not provide enough additional doses of the coronavirus vaccine until the end of June or July 2021, as other states have bought up most of the stocks. Report says, citing the Russian press.
According to the publication, this suggests that the US government probably will not increase Pfizer's vaccine supply as quickly as planned. It raises doubts about whether the country's authorities will be able to adhere to the schedule and vaccinate most citizens by the end of spring or early summer.
Earlier, the American giant Pfizer and the German company BioNTech applied for registration of their coronavirus vaccine in the European Union.
Latest News
15:16
Photo
SOCAR, ILO review potential collaboration prospects
Energy15:08
Estonia to open embassy in Azerbaijan in 2026
Foreign policy15:05
Azerbaijani MFA: Estonian companies eager to operate in Azerbaijan
Business14:55
Samsung dominated Azerbaijan's mobile device market in November
ICT14:46
Azerbaijan, Türkiye strengthen disaster risk reduction cooperation
Foreign policy14:46
Fitch Ratings updates economic growth forecast for Azerbaijan in 2025
Finance14:42
Portuguese President Rebelo de Sousa hospitalised following emergency surgery
Other countries14:34
Photo
ASAN AI Hub platform presented in Baku
Domestic policy14:04